|
AMGN's Revenue Growth by Quarter and Year
Amgen Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AMGN Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
6,839.00
|
6,846.00
|
6,634.00
|
| III Quarter |
September |
6,903.00
|
6,652.00
|
6,706.00
|
6,423.00
|
| II Quarter |
June |
6,986.00
|
6,594.00
|
6,526.00
|
6,206.00
|
| I Quarter |
March |
6,105.00
|
6,238.00
|
5,901.00
|
6,161.00
|
| FY |
|
19,994.00
|
26,323.00
|
25,979.00
|
25,424.00
|
| AMGN Revenue third quarter 2023 Y/Y Growth Comment |
Amgen Inc reported Revenue growth of 3.77% year on year in the third quarter 2023, to $ 6,903.00 millions, this is lower than Amgen Inc 's recent average Revenue growth of 5.54%.
Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 34 other companies have achieved higher Revenue growth. While Amgen Inc ' s Revenue increase of 3.77% ranks overall at the positon no. 1560 in the third quarter 2023.
|
| AMGN Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-0.1 % |
3.2 % |
7.05 % |
| III Quarter |
September |
3.77 % |
-0.81 % |
4.41 % |
11.96 % |
| II Quarter |
June |
5.94 % |
1.04 % |
5.16 % |
5.71 % |
| I Quarter |
March |
-2.13 % |
5.71 % |
-4.22 % |
10.87 % |
| FY |
|
- |
1.32 % |
2.18 % |
8.83 % |
AMGN Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
2.81 % |
2.09 % |
3.29 % |
| III Quarter |
September |
-1.19 % |
0.88 % |
2.76 % |
3.5 % |
| II Quarter |
June |
14.43 % |
5.71 % |
10.59 % |
0.73 % |
| I Quarter |
March |
-10.73 % |
-8.88 % |
-11.05 % |
-0.58 % |
| FY (Year on Year) |
|
- |
1.32 % |
2.18 % |
8.83 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 23.98 % |
5.54 % |
-8.44 % |
| (Dec. 31. 2004) |
|
(March 31, 2009) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 23.98 % |
5.54 % |
-8.44 % |
| (Dec. 31. 2004) |
|
(March 31, 2009) |
|
| Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Amgen Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 14.58 % |
1.55 % |
-11.81 % |
| (June 30. 2014) |
|
|
| AMGN's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2023 Amgen Inc reported decrease in Revenue from the second quarter by -1.19% to $ 6,903.00 millions, from $ 6,986.00 millions released in the previous quarter.
Some seasonal factors which commonly elevate III. Quarter 2023 Revenue, were not able to salvage the III. Quarter for the Amgen Inc , Aiden White, a business insider situated in Houston wrote, he cited little caution conserning AMGN's outlook, he sees additional challenges onward for Amgen Inc and mentioned that average sequential Revenue growth is at 1.55% for Amgen Inc .
Within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 2071. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 14.58 % |
1.55 % |
-11.81 % |
| (June 30. 2014) |
|
|
| AMGN's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2023 Amgen Inc reported decrease in Revenue sequentially by -1.19% to $ 6,903.00 millions, from $ 6,986.00 millions achived in the previous reporting period.
Albeit cyclical circumstance commonly fuel III. Quarter 2023 results, that simply could not be enough to salvage AMGN's outcome, Aiden White, a business insider situated in Houston pointed out and mentioned that average sequential Revenue growth is at 1.55% for AMGN.
Within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 2071. |
|
Amgen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 26,833.00 |
$ 26,582.00 |
$ 26,190.00 |
$ 26,323.00 |
$ 26,330.00 |
| Y / Y Revenue Growth (TTM) |
1.91 % |
0.75 % |
-0.48 % |
1.32 % |
2.18 % |
| Year on Year Revenue Growth Overall
Ranking |
# 716 |
# 1115 |
# 2165 |
# 0 |
# 1661 |
| Seqeuential Revenue Change (TTM) |
0.94 % |
1.5 % |
-0.51 % |
-0.03 % |
-0.2 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 790 |
# 1208 |
# 2414 |
# 0 |
# 1817 |
| Cumulative Revenue growth
Comment |
Although Amgen Inc 's Annual Revenue growth year on year were below company's average 6.15% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.91% year on year, from 0.75% in Jun 30 2023.
In the Healthcare sector 83 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 716, from total ranking in previous quarter at 1115. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.15 % |
-2.75 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.15 % |
-2.75 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 7 |
| Sector |
# 94 |
| S&P 500 |
# 790 |
|
| Cumulative Revenue growth
Comment |
Although Amgen Inc 's Annual Revenue growth year on year were below company's average 6.15% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.91% year on year, from 0.75% in Jun 30 2023.
In the Healthcare sector 83 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 716, from total ranking in previous quarter at 1115. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.15 % |
-2.75 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.15 % |
-2.75 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 7 |
| Sector |
# 94 |
| S&P 500 |
# 790 |
|
6.58%